Dr. Anthony Fauci, the country’s top expert on infectious diseases, said Thursday he feels good about prospects for a vaccine to prevent COVID-19. “You’re going to be hearing over the next months or more about different drugs that are going to go into these different randomized control trials,” he said. “And I feel confident, knowing about what this virus is and what we can do with it, that we will have some sort of therapy.”
More than two dozen Massachusetts companies have announced plans to create vaccines, treatments or devices for COVID-19 — garnering attention from investors but raising questions about long-term success.
Atlas Venture Partner Kevin Bitterman said during a virtual LabCentral discussion Tuesday that it would be “almost criminal” for venture capital firms and their portfolio companies not to consider turning their attention to the development of COVID-19 products. His firm is encouraging its startups to consider development of preventative or therapeutic drugs.
That sentiment is trickling down through the public and private markets.
